Advanced Search
XU XiaoFei, LI Yang, CHEN Lingyun, DAI Heyang, XUE Jiaojiao, LI Qingxia. Research Progress of PNI and CONUT in Breast Cancer[J]. Cancer Research on Prevention and Treatment, 2022, 49(9): 961-964. DOI: 10.3971/j.issn.1000-8578.2022.21.1534
Citation: XU XiaoFei, LI Yang, CHEN Lingyun, DAI Heyang, XUE Jiaojiao, LI Qingxia. Research Progress of PNI and CONUT in Breast Cancer[J]. Cancer Research on Prevention and Treatment, 2022, 49(9): 961-964. DOI: 10.3971/j.issn.1000-8578.2022.21.1534

Research Progress of PNI and CONUT in Breast Cancer

Funding: 

International Science and Technology Cooperation Base Construction Project of Hebei Science and Technology Department 19392411D

More Information
  • Corresponding author:

    LI Qingxia, E-mail: liqingxia@hebmu.edu.cn

  • Received Date: December 29, 2021
  • Revised Date: May 17, 2022
  • Available Online: January 12, 2024
  • Breast cancer has overtaken lung cancer as the most common malignancy in women. Although the early diagnostic rate has continuously improved, recurrence and metastasis remain a problem to be solved. Therefore, scientists should search for effective prognostic markers for breast cancer patients and adopt individualized programs for different patients. Studies have shown that cancer prognosis, to a certain extent, is related to the nutrition inflammation index. Preoperative prognostic nutritional index (PNI) and controlled nutritional status (CONUT) are indicators that comprehensively reflect the nutritional level and inflammatory state of patients, respectively. Different from other cancers, the incidence of breast cancer is related to nutritional status, and an extremely high or low score is not conducive to the prognosis of breast cancer patients. This paper reviews the research progress of PNI and CONUT in breast cancer.

  • Competing interests: The authors declare that they have no competing interests.

  • [1]
    Siegel RL, Miller KD, Fuchs HE, et al. Cancer statistics, 2022[J]. CA Cancer J Clin, 2022, 72(1): 7-33. doi: 10.3322/caac.21708
    [2]
    Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries[J]. CA Cancer J Clin, 2021, 71(3): 209-249. doi: 10.3322/caac.21660
    [3]
    Migita K, Takayama T, Saeki K, et al. The prognostic nutritional index predicts long-term outcomes of gastric cancer patients independent of tumor stage[J]. Ann Surg Oncol, 2013, 20(8): 2647-2654. doi: 10.1245/s10434-013-2926-5
    [4]
    Kim SI, Kim SJ, Kim SJ, et al. Prognostic nutritional index and prognosis in renal cell carcinoma: A systematic review and meta-analysis[J]. Urol Oncol, 2021, 39(10): 623-630. doi: 10.1016/j.urolonc.2021.05.028
    [5]
    Chen L, Bai P, Kong X, et al. Prognostic Nutritional Index (PNI) in Patients With Breast Cancer Treated With Neoadjuvant Chemotherapy as a Useful Prognostic Indicator[J]. Front Cell Dev Biol, 2021, 9: 656741. doi: 10.3389/fcell.2021.656741
    [6]
    Mungmunpuntipantip R, Wiwanitkit V. Prognostic nutritional index, immune nutritional status and COVID-19[J]. Int J Vitam Nutr Res, 2022, 92(1): 3. doi: 10.1024/0300-9831/a000737
    [7]
    Sertdemir AL, İcli A, Aribas A, et al. Prognostic nutritional index and the risk of acute kidney injury in patients with acute coronary syndrome[J]. Rev Assoc Med Bras (1992), 2021, 67(8): 1124-1129. doi: 10.1590/1806-9282.20210460
    [8]
    Perou CM, Sørlie T, Eisen MB, et al. Molecular portraits of human breast tumours[J]. Nature, 2000, 406(6797): 747-752. doi: 10.1038/35021093
    [9]
    赖艳梅, 祝琴, 赵雪云, 等. 预后营养指数对乳腺癌患者预后的关系[J]. 大医生, 2020, 5(16): 116-118. https://www.cnki.com.cn/Article/CJFDTOTAL-GDYY202203029.htm

    Lai YM, Zhu Q, Zhao XY, et al. Relationship Between Prognostic Nutritional Index and Prognosis of Breast Cancer Patients[J]. Da Yi Sheng, 2020, 5(16): 116-118. https://www.cnki.com.cn/Article/CJFDTOTAL-GDYY202203029.htm
    [10]
    单宏杰, 肖迎利, 周雷, 等. 预后营养指数与乳腺癌临床病理关系研究[J]. 蚌埠医学院学报, 2019, 44(2): 212-214. doi: 10.13898/j.cnki.issn.1000-2200.2019.02.022

    Shan HJ, Xiao YL, Zhou L, et al. Study on the relationship between the prognosis nutritional index and clinicopathology of breast carcinoma[J]. Bengbu Yi Xue Yuan Xue Bao, 2019, 44(2): 212-214. doi: 10.13898/j.cnki.issn.1000-2200.2019.02.022
    [11]
    Wu X, Ding M, Lin J. Three-microRNA expression signature predicts survival in triple-negative breast cancer[J]. Oncol Lett, 2020, 19(1): 301-308.
    [12]
    Yang Z, Zhang B, Hou LK, et al. Pre-operative prognostic nutritional index predicts the outcomes for triple-negative breast cancer[J]. Tumour Biol, 2014, 35(12): 12165-12171. doi: 10.1007/s13277-014-2524-6
    [13]
    Mohri T, Mohri Y, Shigemori T, et al. Impact of prognostic nutritional index on long-term outcomes in patients with breast cancer[J]. World J Surg Oncol, 2016, 14(1): 170. doi: 10.1186/s12957-016-0920-7
    [14]
    Frasier LL, Holden S, Holden T, et al. Temporal Trends in Postmastectomy Radiation Therapy and Breast Reconstruction Associated With Changes in National Comprehensive Cancer Network Guidelines[J]. JAMA Oncol, 2016, 2(1): 95-101. doi: 10.1001/jamaoncol.2015.3717
    [15]
    Hua X, Long ZQ, Huang X, et al. The Value of Prognostic Nutritional Index (PNI) in Predicting Survival and Guiding Radiotherapy of Patients With T1-2N1 Breast Cancer[J]. Front Oncol, 2019, 9: 1562.
    [16]
    Kerr J, Anderson C, Lippman SM. Physical activity, sedentary behaviour, diet, and cancer: an update and emerging new evidence[J]. Lancet Oncol, 2017, 18(8): e457-e471. doi: 10.1016/S1470-2045(17)30411-4
    [17]
    Okadome K, Baba Y, Yagi T, et al. Prognostic Nutritional Index, Tumor-infiltrating Lymphocytes, and Prognosis in Patients with Esophageal Cancer[J]. Ann Surg, 2020, 271(4): 693-700. doi: 10.1097/SLA.0000000000002985
    [18]
    Wang Y, Battseren B, Yin W, et al. Predictive and prognostic value of prognostic nutritional index for locally advanced breast cancer[J]. Gland Surg, 2019, 8(6): 618-626. doi: 10.21037/gs.2019.10.08
    [19]
    Tokunaga R, Sakamoto Y, Nakagawa S, et al. CONUT: a novel independent predictive score for colorectal cancer patients undergoing potentially curative resection[J]. Int J Colorectal Dis, 2017, 32(1): 99-106. doi: 10.1007/s00384-016-2668-5
    [20]
    Harimoto N, Yoshizumi T, Sakata K, et al. Prognostic Significance of Preoperative Controlling Nutritional Status (CONUT) Score in Patients Undergoing Hepatic Resection for Hepatocellular Carcinoma[J]. World J Surg, 2017, 41(11): 2805-2812. doi: 10.1007/s00268-017-4097-1
    [21]
    Yılmaz A, Tekin SB, Bilici M, et al. The Significance of Controlling Nutritional Status (CONUT) Score as a Novel Prognostic Parameter in Small Cell Lung Cancer[J]. Lung, 2020, 198(4): 695-704. doi: 10.1007/s00408-020-00361-2
    [22]
    Li W, Li M, Wang T, et al. Controlling Nutritional Status (CONUT) score is a prognostic factor in patients with resected breast cancer[J]. Sci Rep, 2020, 10(1): 6633. doi: 10.1038/s41598-020-63610-7
    [23]
    Takahashi T, Watanabe T, Otaki Y, et al. Prognostic significance of the controlling nutritional (CONUT) score in patients with acute coronary syndrome[J]. Heart Vessels, 2021, 36(8): 1109-1116. doi: 10.1007/s00380-021-01792-4
    [24]
    Bengelloun AK, Ortega GJ, Ancochea J, et al. Usefulness of the CONUT index upon hospital admission as a potential prognostic indicator of COVID-19 health outcomes[J]. Chin Med J (Engl), 2021, 135(2): 187-193.
    [25]
    Huang ZZ, Song CG, Huang JJ, et al. Prognostic significance of the Controlling Nutritional Status (CONUT) score in surgically treated breast cancer patients[J]. Gland Surg, 2020, 9(5): 1370-1379. doi: 10.21037/gs-20-294
    [26]
    Ishihara H, Kondo T, Yoshida K, et al. Preoperative controlling nutritional status (CONUT) score as a novel predictive biomarker of survival in patients with localized urothelial carcinoma of the upper urinary tract treated with radical nephroureterectomy[J]. Urol Oncol, 2017, 35(9): 539. e9-539. e16. doi: 10.1016/j.urolonc.2017.04.012
    [27]
    Yang Z, Zheng Y, Wu Z, et al. Association between pre-diagnostic serum albumin and cancer risk: Results from a prospective population-based study[J]. Cancer Med, 2021, 10(12): 4054-4065. doi: 10.1002/cam4.3937
    [28]
    Liu X, Meng QH, Ye Y, et al. Prognostic significance of pretreatment serum levels of albumin, LDH and total bilirubin in patients with non-metastatic breast cancer[J]. Carcinogenesis, 2015, 36(2): 243-248. doi: 10.1093/carcin/bgu247
    [29]
    Singh N, Baby D, Rajguru JP, et al. Inflammation and cancer[J]. Ann Afr Med, 2019, 18(3): 121-126. doi: 10.4103/aam.aam_56_18
    [30]
    徐良, 张百红. 淋巴细胞相关炎性反应指标与乳腺癌预后的相关性[J]. 肿瘤防治研究, 2020, 47(12): 936-941. doi: 10.3971/j.issn.1000-8578.2020.20.1179

    Xu L, Zhang BH. Prognostic Value of Lymphocyte-associated Inflammatory Markers in Breast Cancer[J]. Zhong Liu Fang Zhi Yan Jiu, 2020, 47(12): 936-941. doi: 10.3971/j.issn.1000-8578.2020.20.1179
    [31]
    Hu B, Yang XR, Xu Y, et al. Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma[J]. Clin Cancer Res, 2014, 20(23): 6212-6222. doi: 10.1158/1078-0432.CCR-14-0442
    [32]
    Jiang C, Lu Y, Zhang S, et al. Systemic Immune-Inflammation Index Is Superior to Neutrophil to Lymphocyte Ratio in Prognostic Assessment of Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy[J]. Biomed Res Int, 2020, 2020: 7961568.

Catalog

    Article views (1884) PDF downloads (284) Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return